Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

By Sneha S K June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to ...

ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels

Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of ...

DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes

DXCM reports positive CONNECT trial results as Dexcom G7 improves HbA1c and time in range in adults with Type 2 diabetes not using insulin.
Drug Delivery Business

Dexcom study highlights benefits of G7 CGM in non-insulin type 2 diabetes

Researchers shared findings today at the American Diabetes Association Scientific Sessions (ADA 2026) in New Orleans. San ...

Clinical wins boost Dexcom growth story in type 2 diabetes

DexCom Inc. DXCM stock is trading higher on Monday after the diabetes management company reported positive results from its ...

Dexcom study finds G7 glucose monitor improves blood sugar control in type 2 diabetes patients

A new study presented at the American Diabetes Association found that Dexcom’s G7 continuous glucose monitor significantly ...
Fierce Biotech

ADA: Dexcom CGM shows benefit in non-insulin diabetes patients

A Dexcom continuous glucose monitor (CGM) helped adults with type 2 diabetes not using insulin improve blood sugar control in ...

Dexcom alerts users after faulty G7 glucose sensors stolen and resold

People with diabetes who use the Dexcom G7 continuous glucose monitoring system need to check the lot numbers on sensors. Dexcom reported on May 26, 2026, that through internal reviews it had ...